| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.30▲ | 1.31▼ | 1.31▼ | 1.18▲ | 1.21▲ |
| MA10 | 1.30▼ | 1.32▼ | 1.26▲ | 1.18▲ | 1.23▲ |
| MA20 | 1.30▼ | 1.25▲ | 1.22▲ | 1.22▲ | 1.24▲ |
| MA50 | 1.32▼ | 1.22▲ | 1.20▲ | 1.24▲ | 6.14▼ |
| MA100 | 1.27▲ | 1.20▲ | 1.22▲ | 1.26▲ | 7.35▼ |
| MA200 | 1.23▲ | 1.24▲ | 1.24▲ | 5.77▼ | 15.51▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | 0.002▲ | 0.015▲ | -0.001▼ | 0.343▲ |
| RSI | 44.687▼ | 60.429▲ | 63.300▲ | 56.148▲ | 33.162▼ |
| STOCH | 20.833 | 28.446 | 73.981 | 41.444 | 42.577 |
| WILL %R | -66.667 | -32.000 | -30.189 | -32.258 | -32.727 |
| CCI | -73.203 | -13.208 | 54.625 | 211.902▲ | 30.186 |
| ▲ PSAR&MOM | $IGMS PSAR Switch Up + Momentum | Set Alert |
| ▲ RSI&VOL | $IGMS RSI Cross Up and Volume | Set Alert |
| RSI | $IGMS RSI(14) Crossed Above 50 | Set Alert |
| MA | $IGMS Price Crossed Above MA(50) | Set Alert |
| MA | $IGMS Price Crossed Above MA(26) | Set Alert |
| MA | $IGMS Price Crossed Above MA(13) | Set Alert |
| MA | $IGMS Price Crossed Above MA(7) | Set Alert |
| ▲ GAP | $IGMS Open Gap Up %5 | Set Alert |
| ▲ GAP | $IGMS Open Gap Up %3 | Set Alert |
| ▲ GAP | $IGMS Open Gap Up %2 | Set Alert |
| ▲ BREAK | $IGMS Price Breaks 10 Days High | Set Alert |
| CDL | $IGMS Shooting Star Candlestick Pattern Detected | Set Alert |
| CDL | $IGMS Doji Star Candlestick Pattern Detected | Set Alert |
| CDL | $IGMS Doji Candlestick Pattern Detected | Set Alert |
|
Tuesday, July 01, 2025 12:42 PM
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of IGM Biosciences, Inc. (NASDAQ: IGMS) to Concentra Biosciences, LLC is fair to IGM shareholders. Under the terms of ...
|
|
Tuesday, July 01, 2025 06:32 AM
IGM Biosciences Inc. (NASDAQ:IGMS) saw its stock jump 20% after revealing it has reached a definitive agreement to be acquired by Concentra Biosciences in a cash-and-contingent deal. According to the ...
|
|
Tuesday, July 01, 2025 05:58 AM
IGM Biosciences, Inc. (Nasdaq: IGMS), a biotechnology company that has focused on developing engineered IgM-based therapeutic antibodies, today announced that it has entered into a definitive merger ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/07/25 | 1.295 | 1.39 | 1.29 | 1.29 | 13,492,798 |
| 30/06/25 | 1.08 | 1.1596 | 1.08 | 1.12 | 241,504 |
| 27/06/25 | 1.21 | 1.24 | 1.08 | 1.08 | 2,458,528 |
| 26/06/25 | 1.20 | 1.26 | 1.19 | 1.22 | 72,306 |
| 25/06/25 | 1.18 | 1.24 | 1.16 | 1.21 | 99,793 |
| 24/06/25 | 1.18 | 1.225 | 1.1404 | 1.18 | 102,666 |
| 23/06/25 | 1.15 | 1.20 | 1.12 | 1.16 | 149,774 |
| 20/06/25 | 1.17 | 1.22 | 1.16 | 1.17 | 241,889 |
| 18/06/25 | 1.17 | 1.2399 | 1.17 | 1.17 | 127,150 |
| 17/06/25 | 1.22 | 1.24 | 1.165 | 1.19 | 138,885 |
|
|
||||
|
|
||||
|
|